Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases (Q72758247)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

author name string

D Sorbi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

M Fadly

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

R Hicks

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

S Alexander

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

L Arbeit

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

language of work or name

English

0 references

publication date

1 December 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

1266-1272

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.1993.378

29 October 2019

exact match

0 references

cites work

Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Reduction of proteinuria by angiotensin converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Effect of nifedipine and captopril on glomerular hyperfiltration in normotensive man

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Effect of captopril on heavy proteinuria in azotemic diabetics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Effects of Converting-Enzyme Inhibition on Barrier Function in Diabetic Glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Control of hypertension with the angiotensin converting enzyme inhibitor captopril reduces glomerular proteinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Enalapril Can Treat the Proteinuria of Membranous Glomerulonephritis Without Detriment to Systemic or Renal Hemodynamics

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Platelet-derived growth factor (PDGF)-induced phospholipase C-mediated hydrolysis of phosphoinositides in vascular smooth muscle cells--different sensitivity of PDGF- and angiotensin II-induced phospholipase C reactions to protein kinase C-activatin

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Amiloride sensitive activation of S6 kinase by angiotensin II in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Influence of angiotensin converting enzyme inhibitor (captopril) on kidney epithelial cells in vitro: studies on potassium (86Rb) influx and cellular proliferation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Captopril does not scavenge superoxide: captopril prevents O2-. production by chelating copper.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Proteolytic enzymes as mediators of glomerular injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Proteinases and glomerular matrix turnover

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Gelatinase secretion by glomerular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Type IV collagenases in tumor invasion and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Partial purification and characterization of a neutral protease which cleaves type IV collagen

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Secretion of 72 kDa type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Tetracycline inhibition identifies the cellular origin of interstitial collagenases in human periodontal diseases in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

The future of angiotensin-converting enzyme inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Neutral proteinase activity produced in vitro by cells of the glomerular mesangium

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

A nonradioactive assay for type IV collagen degradation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Metal binding peptide inhibitors of vertebrate collagenase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Inhibition of mammalian collagenases by thiol-containing peptides

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Inhibition of human collagenases by sulfur-based substrate analogs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Pharmacokinetics of captopril and its effects on blood pressure during acute and chronic administration and in relation to food intake.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1993.378

7 January 2021

Identifiers

DOI

10.1038/KI.1993.378

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8301928%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference